Who Discovered The Recommended Frequency Of Vidalista CT 20 Mg Use?
The recommended frequency of Vidalista CT 20 mg use was not discovered by a single person. Instead, it was established through clinical research and regulatory evaluation of its active ingredient, tadalafil, which is the same drug used in Vidalista formulations.
Tadalafil was originally developed by pharmaceutical researchers working on treatments for erectile dysfunction (ED). During clinical trials, scientists studied how long the drug stays active in the body, its safety profile, and how often it can be safely taken. These studies showed that tadalafil has a long half-life (about 17.5 hours), allowing its effects to last up to 36 hours in many users. Based on this pharmacological data, researchers determined that taking tadalafil more than once in 24 hours is unnecessary and may increase side effects.
Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and other global health authorities reviewed these clinical trial results before approving standard dosing guidelines. These guidelines were then adopted for all tadalafil-based products, including Vidalista CT 20 mg.
The “CT” (chewable tablet) form does not change the drug’s recommended frequency; it only affects how quickly it is absorbed. Therefore, the once-daily or once-per-24-hour limit is based on scientific evidence, not an individual inventor.
In summary, the recommended use frequency comes from large-scale clinical studies and regulatory medical approval processes, ensuring both effectiveness and safety for users.  |
M'inscrire 
Me connecter 
Mot de passe oublié 
Retour au forum
